SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-072486
Filing Date
2011-03-21
Accepted
2011-03-21 16:11:54
Documents
4
Period of Report
2011-03-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 26423
2 FIFTH AMENDMENT TO THE LICENSE AGREEMENT dex10121.htm EX-10.121 12332
3 PRESS RELEASE dex991.htm EX-99.1 10609
4 GRAPHIC g165207g82j97.jpg GRAPHIC 6203
  Complete submission text file 0001193125-11-072486.txt   59284
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16467 | Film No.: 11701411
SIC: 2834 Pharmaceutical Preparations